Sarah Ketterer's BSX Position Overview
Sarah Ketterer (via Causeway Capital Management LLC) currently holds 720,339 shares of Boston Scientific Corporation (BSX) worth $30.74 M, representing 0.33% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Sarah Ketterer has initiated a new position in BSX, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Sarah Ketterer's Boston Scientific Corporation (BSX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Boston Scientific Corporation (BSX) Trades by Sarah Ketterer
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +720,339 | New Buy | 720,339 | $42.68 |
Sarah Ketterer's Boston Scientific Corporation Investment FAQs
Sarah Ketterer first purchased Boston Scientific Corporation (BSX) in Q2 2026, acquiring 720,339 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Sarah Ketterer has held Boston Scientific Corporation (BSX) for 1 quarters since Q2 2026.
Sarah Ketterer's largest addition to Boston Scientific Corporation (BSX) was in Q2 2026, adding 720,339 shares worth $30.74 M.
According to the latest 13F filing for Q2 2026, Sarah Ketterer's firm, Causeway Capital Management LLC, owns 720,339 shares of Boston Scientific Corporation (BSX), valued at approximately $30.74 M.
As of the Q2 2026 filing, Boston Scientific Corporation (BSX) represents approximately 0.33% of Sarah Ketterer's publicly disclosed stock portfolio, making it one of their key holdings.
Sarah Ketterer's peak holding in Boston Scientific Corporation (BSX) was 720,339 shares, as reported at the end of Q2 2026.